Schonfeld Strategic Advisors LLC Rocket Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$15.07 - $24.05 $297,240 - $474,362	-19,724 Reduced 65.48%	10,400 $213,000
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $499,757 - $710,926	30,124 New	30,124 $598,000
Q4 2022 Feb 14, 2023	SELL	$15.5 - $22.76 $348,564 - $511,826	-22,488 Reduced 30.59%	51,024 $998,000
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $909,343 - $1.35 Million	73,512 New	73,512 $1.17 Million
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $544,824 - $980,352	-41,400 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $642,802 - $1.08 Million	-29,870 Reduced 41.91%	41,400 $903,000
Q3 2021 Nov 16, 2021	BUY	$27.42 - $48.97 $961,537 - $1.72 Million	35,067 Added 96.86%	71,270 $2.13 Million
Q2 2021 Nov 16, 2021	SELL	$39.41 - $47.25 $1.43 Million - $1.71 Million	-36,203 Reduced 50.0%	36,203 $1.6 Million
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $1.42 Million - $1.7 Million	35,905 Added 98.37%	72,406 $3.21 Million
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $134,830 - $205,046	-3,111 Reduced 7.85%	36,501 $1.62 Million
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $316,670 - $809,615	13,591 Added 52.23%	39,612 $2.17 Million
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $511,147 - $712,863	-24,934 Reduced 48.93%	26,021 $1,000
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $678,720 - $1.15 Million	50,955 New	50,955 $1.07 Million
Q1 2020 May 15, 2020	SELL	$9.71 - $25.11 $353,783 - $914,882	-36,435 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$11.07 - $24.23 $433,556 - $948,967	-39,165 Reduced 51.81%	36,435 $829,000
Q3 2019 Nov 14, 2019	SELL	$10.85 - $14.78 $1.16 Million - $1.59 Million	-107,300 Reduced 58.67%	75,600 $881,000
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.81 $2.37 Million - $3.14 Million	158,300 Added 643.5%	182,900 $2.74 Million
Q1 2019 May 15, 2019	SELL	$13.45 - $19.01 $1.04 Million - $1.48 Million	-77,600 Reduced 75.93%	24,600 $432,000
Q4 2018 Feb 14, 2019	BUY	$11.21 - $23.53 $865,412 - $1.82 Million	77,200 Added 308.8%	102,200 $1.51 Million
Q3 2018 Nov 14, 2018	BUY	$18.5 - $25.49 $462,500 - $637,250	25,000 New	25,000 $616,000
Q2 2018 Aug 14, 2018	SELL	$14.58 - $23.0 $356,626 - $562,580	-24,460 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$11.68 - $19.19 $285,692 - $469,387	24,460 New	24,460 $459,000

Others Institutions Holding RCKT

# of Institutions

210

Shares Held

93.3M

Call Options Held

319K

Put Options Held

70.3K

Rtw Investments, LP New York, NY

17.7M
Shares

$182 Million
5.21% of portfolio
Wellington Management Group LLP Boston, MA

11.2M
Shares

$116 Million
0.04% of portfolio
Black Rock Inc. New York, NY

6.19M
Shares

$63.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.54M
Shares

$57.1 Million
0.0% of portfolio
Westfield Capital Management CO LP Boston, MA

4.49M
Shares

$46.3 Million
0.39% of portfolio

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $780M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account